Okomera logo

Okomera

Automated 3D organoid screening technology

30 employees · est. 2020 · Paris, France

VS
Reaction Biology logo

Reaction Biology

Contract research organization with commitment to quality data and quality support. Let's Discover Together.

146 employees · est. 2001 · Malvern, United States

Reaction Biology is the older company (2020 vs 2001); Reaction Biology is the larger of the two.

Side-by-Side Comparison

Okomera Reaction Biology
Founded
2020 2001 older
Headquarters
Paris, France Malvern, United States
Employees
30 146 larger
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Pharmaceutical
Funding Stage
Grant Acquired
Total Funding
$11.70M Not tracked yet
Funding Rounds
4 1
Services
Automated 3D organoid screening technology, AI analysis platform, Personalized medicine Integrated Drug Discovery Solutions, Cell-based and Biochemical Assays, Biophysical Assays, Custom Drug Discovery Services, In Vivo Models and Pharmacology
Target Customers
Biotech companies, Pharmaceutical companies, Medical research institutions Pharmaceutical Companies, Biotech Companies, Academic Research Institutions
Taxonomy
Biotech, Drug Discovery, 3D Organoid Screening, Precision Medicine, Cancer Research, Automation Technology, Tumor Biopsy Research, Preclinical Predictivity, CRISPR Technology, T-cell Assays, Cytotoxicity Assays Contract Research Organization, Drug Discovery, Therapeutic Development, Biochemical Assays, Biophysical Assays, Cell Assays, High Throughput Screening, Kinase Targets, Epigenetic Targets, Methyltransferase Assays, Protein Production, Electrophysiological Assays, Enzymology, Custom Assay Development, FDA Approved Therapies
Website
okomera.com reactionbiology.com
Okomera logo

About Okomera

Okomera is a biotechnology startup based in France that specializes in automated 3D organoid screening technology. Since its founding in 2020, the company has focused on accelerating drug discovery through the integration of standard assays on chip, such as CRISPR, T-cell, and cytotoxicity, with the...

Reaction Biology logo

About Reaction Biology

Reaction Biology, established in 2001, stands as a leading Contract Research Organization (CRO) in the Biotechnology and Pharmaceutical industries. Its slogan, "Let's Discover Together," encapsulates its commitment to delivering quality and collaborative research support. The company operates with a...

We will tell you when either one moves

BounceWatch watches Okomera and Reaction Biology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Okomera and Reaction Biology — by email.

Frequently Asked Questions

Okomera — Automated 3D organoid screening technology. Reaction Biology — Contract research organization with commitment to quality data and quality support. Let's Discover Together.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Okomera has raised $11.70M while Reaction Biology has raised undisclosed funding.
Okomera and Reaction Biology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Okomera with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Okomera on 11 Jun 2025, and Reaction Biology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy